4DMedical Limited (ASX:4DX)
Australia · Delayed Price · Currency is AUD 4.220
-0.420 (-9.05%)
Aug 7, 2026, 4:10 PM AEST
4DMedical Financials Overview
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Revenue Revenue Growth | 5.81 | 5.85 | 3.75 | 0.72 | 1.05 | 0.22 |
Revenue Growth | -0.73% | 55.91% | 422.45% | -31.84% | 385.90% | -82.39% |
Gross Profit Gross Profit Growth | 5.34 | 5.39 | 3.52 | 0.68 | 0.28 | 0.13 |
Operating Income Operating Income Growth | -50.52 | -47.5 | -45.03 | -44.57 | -36.75 | -24.34 |
Net Income Net Income Growth | -172.93 | -30.07 | -35.98 | -31.46 | -24.59 | -21.42 |
Earnings Per Share EPS Growth | -0.41 | -0.14 | -0.11 | -0.10 | -0.08 | -0.08 |
EPS Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
United States of America United States of America Growth | 5.61 | 5.73 | 2.93 | 0.18 | 0.95 | 0.12 |
Australia Australia Growth | 0.21 | 0.12 | 0.82 | 0.54 | 0.1 | 0.1 |
Total Total Growth | 5.81 | 5.85 | 3.75 | 0.72 | 1.05 | 0.22 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Cash & Investments Cash & Investments Growth | 56.76 | 6.88 | 30.61 | 69.58 | 51.11 | 80.88 |
Total Debt Total Debt Growth | 10.24 | 4.31 | 5.12 | 5.14 | 6.24 | 1.69 |
Net Cash (Debt) Net Cash Growth | 46.52 | 2.57 | 25.49 | 64.44 | 44.88 | 79.19 |
Net Cash Growth | 1709.56% | -89.91% | -60.45% | 43.59% | -43.33% | - |
Net Cash Per Share Net Cash Per Share Growth | 0.09 | 0.01 | 0.07 | 0.21 | 0.14 | 0.28 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Operating Cash Flow Operating Cash Flow Growth | -32.99 | -34.48 | -30.87 | -22.65 | -25.27 | -14.52 |
Capital Expenditures CapEx Growth | -0.19 | -0.09 | -0.16 | -0.42 | -2.65 | -0.58 |
Free Cash Flow Free Cash Flow Growth | -33.17 | -34.56 | -31.02 | -23.07 | -27.92 | -15.1 |
Free Cash Flow Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Gross Margin | 91.87% | 92.07% | 93.69% | 95.25% | 26.62% | 57.67% |
Operating Margin | -869.40% | -811.49% | -1199.53% | -6202.49% | -3485.78% | -11217.15% |
Pretax Margin | -2993.83% | -515.20% | -957.05% | -4333.06% | -2328.53% | -9865.16% |
Profit Margin | -2976.16% | -513.72% | -958.34% | -4378.05% | -2332.63% | -9872.21% |
FCF Margin | -570.95% | -590.45% | -826.34% | -3211.05% | -2647.86% | -6957.55% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 8, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
PS Ratio | 435.51 | 19.09 | 56.84 | 321.80 | 164.80 | 1662.62 |